(Q34660081)

English

Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

based on heuristic

inferred from title

Gunnar Folprecht

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Thomas Gruenberger

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Wolf Otto Bechstein

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

H-R Raab

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

J Weitz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

F Lordick

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

J T Hartmann

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

J Stoehlmacher-Williams

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

H Lang

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

T Liersch

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

D Ockert

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

D Jaeger

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

U Steger

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

T Suedhoff

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

A Rentsch

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

C-H Köhne

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

27 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1018-1025

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24585720%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Surgical management and outcomes of colorectal cancer liver metastases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

A systematic review of repeat hepatectomy for recurrent colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Patients' expectations about effects of chemotherapy for advanced cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Patients' perspectives on palliative chemotherapy of colorectal and non--colorectal cancer: a prospective study in a chemotherapy- experienced population

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Prognostic models for outcome following liver resection for colorectal cancer metastases: A systematic review.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU088

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34660081&oldid=2087464894"